The purpose of this national diagnosis and treatment protocol (PNDS) is to outline to health providers the optimum management and integrated care pathway for patients with long-term conditions (ALD), particularly with status ALD 11: xeroderma pigmentosum (XP).
See also
HAS opinions and decisions
17/06/2009
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
84XUnrKqqsk6v2c7
Listen
